Cyclic di-AMP and its Role in DNA Repair and Drug Resistance in Mycobacterium
Author Information
Author(s): Mudgal Sudhanshu, Goyal Nisha, Kasi Manikandan, Saginela Rahul, Singhal Anusha, Nandi Soumyadeep, Mahmud A K M Firoj, Muniyappa Kalappa, Sinha Krishna Murari, Bahar Ivet
Primary Institution: Amity Institute of Biotechnology, Amity University Haryana
Hypothesis
Cyclic di-AMP regulates genome stability and drug resistance in Mycobacterium through RecA-dependent and RecA-independent recombination.
Conclusion
The absence of cyclic di-AMP leads to increased DNA recombination and higher drug resistance in Mycobacterium smegmatis.
Supporting Evidence
- Cells lacking cyclic di-AMP showed increased levels of homology-directed repair and higher mutation rates.
- The absence of cyclic di-AMP resulted in a two-fold increase in rifampicin-resistant colonies.
- Cyclic di-AMP inhibits RecA-mediated self-cleavage of LexA repressor, enhancing the SOS response.
- Complementation with wild-type RecA restored drug resistance in ΔrecA mutants.
Takeaway
Cyclic di-AMP helps bacteria fix their DNA and stay healthy; without it, they can get more mutations and become resistant to drugs.
Methodology
The study used genetic assays to analyze DNA repair pathways in Mycobacterium smegmatis, focusing on the effects of cyclic di-AMP on RecA-mediated and RecA-independent homologous recombination.
Limitations
The precise mechanisms by which cyclic di-AMP regulates RecA-independent pathways remain unclear.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website